Netherlands Biotechnology Congress, NBC-25

NorthX Biologics is proud to be presenting at NBC-25, the Netherlands Biotechnology Congress, taking place on Tuesday, 23 September 2025 at the Omnia Congress Centre in Wageningen. This premier event brings together leading biotech experts from across the Netherlands, and we’re excited to contribute to the dialogue shaping the future of biotechnology. Don’t miss the chance to connect with our team and hear from our Deputy CEO, Eva-Karin Gidlund, who will be featured as one of the keynote speakers.

When: September 23, 2025
Where: Wageningen, the Netherlands

Read more about the event here.

If you are interested in booking a meeting in advance, please fill out the form here.

About NorthX Biologics AB

NorthX Biologics is a CDMO and Innovation Hub in Advanced Biologics, with +30 years of GMP production experience. The team provides process development and GMP manufacturing services with expertise in plasmid DNA, mRNA, proteins, cells and other advanced biologics. Headquartered in the heart of Sweden, the team serves customers worldwide and in 2021 was recognized as a national innovation hub for advanced therapeutics and vaccines. NorthX Biologics has the ambition to become a leading cell and gene therapy manufacturer and partner of choice for innovative drug development companies.

For more news, follow us on LinkedIn